1/15
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Sleep Apnea
A sleep disorder characterized by repeated episodes of airway obstruction, leading to intermittent hypoxia and sleep disruption
Obstructive, Central, Mixed
Types of sleep apnea
__________ sleep apnea: most common, caused by upper airway collapse
_______ sleep apnea: Reduced respiratory effort d/t brainstem dysfunction
______ sleep apnea: combination of OSA and CSA
middle, >, 30, neck, abnormalities, sedative, 60
Sleep Apnea
Common in _______-aged and older adults
Men _ Women (until post-menopause)
Risk Factors
Obesity (BMI >__)
Large ____ circumference (>17” in men, >16” in women)
Craniofacial ______________
Smoking, alcohol use, ________ medications
Family history
Age >__ years
tone, decreases, cessation, sympathetic, fatigue, hypertension
Sleep Apnea Pathophysiology
During sleep, muscle ____ of the upper airway _________ → airway collapse → transient _________ of breathing
Leads to
Hypoxia and Hypercapnia → increased ___________ activity
Arousal from sleep → fragmented sleep and daytime _________
Increased risk of _____________, cardiovascular disease, metabolic syndrome
snoring, choking, awakenings, sleepiness, headaches, irritability
Sleep Apnea Clinical Presentation
Nighttime Symptoms
Loud ________
Witnessed apneas, gasping/________ episodes
Frequent ____________
Daytime Symptoms
Excessive daytime __________ (EDS)
Morning __________
difficulty concentrating, memory issues
____________, mood changes
STOP-BANG, Epworth, polysomnography, home
Sleep Apnea Diagnosis
Screening Tools
____-_____ Questionnaire: identifies high-risk individuals
________ Sleepiness Scale (ESS): Assesses daytime sleepiness
Definitive Diagnosis
_______________ (PSG) (Gold Standard): measures sleep apnea-hypopnea index (AHI)
____ Sleep Apnea Test: alternative for moderate-to-severe OSA cases
weight loss, sedatives, positional, positive, mandibular, surgery
Sleep Apnea Treatment and Management
Lifestyle Modifications
______ ____
Avoid alcohol, __________
__________ therapy (avoid supine position)
First line treatment
Continuous ________ airway pressure: gold standard for moderate-severe OSA
Alternative Therapies
__________ advancement devices (MADs) for mild-moderate cases
Upper airway ________ for refractory cases
Treatment of Central Sleep Apnea
Adaptive servo-ventilation, oxygen therapy
hypertension, stroke, insulin, dementia
Sleep Apnea Complications
Cardiovascular Risks
____________
Atrial Fibrillation
Myocardial infarction, ______
Metabolic Effects
_______ resistance, type 2 diabetes
Neurocognitive Impairment
Increased risk of _________, depression
Increased accident risk
higher likelihood of motor vehicle accidents
Obesity Hypoventilation Syndrome (OHS)
a disorder characterized by chronic daytime hypoventilation (PaCO2 >45 mmHg) in obese individuals (BMI > 30 kg/m²) without an alternative cause of hypoventilation
90
What percentage of individuals with OHS also have obstructive sleep apnea?
50, male, 50, 17, hypoxia
OHS Major Risk Factors
Obesity (BMI > 30 kg/m², especially >__ kg/m²)
____ sex
Age > __ years
Neck circumference > __ inches
Chronic ________-related conditions
restriction, central, hypercapnia, leptin
OHS Pathophysiology
Obesity leads to:
Increased work of breathing d/t chest wall __________
Impaired _______ respiratory drive (blunted response to CO2)
Nocturnal hypoventilation → daytime ___________
Increased _______ resistance, impairing ventilatory drive
daytime, headaches, cognitive, snoring, restless, hypoxia
OHS Clinical Presentation
Daytime Symptoms
Excessive ________ sleepiness
Morning _________ (d/t CO2 retention overnight)
Fatigue, depression, _________ impairment
Nocturnal Symptoms
Loud _______, witnessed apneas
Choking/gasping episodes
________ sleep
Physical Exam Findings
Obesity
Signs of chronic _______: cyanosis, polycythemia, lower extremity edema
obese, 45, 70, hypoxia, bicarbonate, restrictive, right
OHS Diagnosis
Clinical suspicion in ______ patients with hypercapnia and hypoxia
Key Diagnostic Tests
ABG: PaCO2 > __ mmHg + PaO2 < __ mmHg
Polysomnography: Evaluates OSA, nocturnal _______
Serum ___________ (>27 mEq/L): suggests chronic CO2 retention
PFTs: _________ pattern
CXR & Echocardiography: To assess for _____ heart failure (cor pulmonale)
positive, CPAP, BiPAP, diet, alcohol, sedatives, diuretics
OHS Treatment and Management
First Line Therapy:
________ Airway Pressure (PAP) Therapy:
____ (if OSA present)
_____ (if persistent hypercapnia despite CPAP)
Lifestyle Modifications
Weight loss
Physical Activity and _____ changes
Smoking/_______ cessation
Avoid use of _________
Medical Therapy for Symptom Management
O2 therapy if hypoxemia persists despite PAP therapy
_________ for fluid overload in cor pulmonale
early, hypertension, failure, stroke
OHS
Prognosis: Improved with_____ PAP therapy and weight loss
Potential Complications
Pulmonary ___________ → right heart failure (cor pulmonale)
Severe hypoxemia and hypercapnic respiratory _______
Increased risk of cardiovascular disease (_____, MI)